Literature DB >> 23860802

Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.

P Heusch1, C Buchbender, J Köhler, F Nensa, K Beiderwellen, H Kühl, R S Lanzman, H J Wittsack, B Gomez, T Gauler, M Schuler, M Forsting, A Bockisch, G Antoch, T A Heusner.   

Abstract

PURPOSE: To compare the apparent diffusion coefficient (ADC) in non-small cell lung cancer lesions with standardized uptake values (SUV) derived from combined 18F-fluoro-deoxy-glucose-positron emission tomography/magnetic resonance imaging (FDG-PET/MRI) and those derived from FDG-PET/CT.
MATERIALS AND METHODS: In 18 consecutive patients with histologically proven NSCLC (17 men, 1 woman; mean age, 61 ± 12 years), whole-body FDG-PET/MRI was performed after whole-body FDG-PET/CT. Regions of interest (ROI) encompassing the entire primary tumor were drawn into FDG-PET/CT and FDG-PET/MR images to determine the maximum and mean standardized uptake value (SUVmax; SUVmean) and into ADC parameter maps to assess mean ADC values. Pearson's correlation coefficients were calculated to compare SUV and ADC values.
RESULTS: The SUVmax of NSCLC was 12.3 ± 4.8 [mean ±SD], and the SUVmean was 7.2 ± 2.8 as assessed by FDG-PET/MRI. The SUVmax and SUVmean derived from FDG-PET/CT and FDG-PET/MRI correlated well (R = 0.93; p < 0.001 and R = 0.92; p < 0.001, respectively). The ADCmean of the pulmonary tumors was 187.9 ± 88.8 × 10-5 mm²/s [mean ± SD]. The ADCmean exhibited a significant inverse correlation with the SUVmax (R = -0.72; p < 0.001) as well as with the SUVmean assessed by FDG-PET/MRI (R = -0.71; p < 0.001).
CONCLUSION: This simultaneous PET/MRI study corroborates the assumed significant inverse correlation between increased metabolic activity on FDG-PET and restricted diffusion on DWI in NSCLC.Citation Format: © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23860802     DOI: 10.1055/s-0033-1350110

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  15 in total

1.  Thoracic staging of non-small-cell lung cancer using integrated (18)F-FDG PET/MR imaging: diagnostic value of different MR sequences.

Authors:  Benedikt Schaarschmidt; Christian Buchbender; Benedikt Gomez; Christian Rubbert; Florian Hild; Jens Köhler; Johannes Grueneisen; Henning Reis; Verena Ruhlmann; Axel Wetter; Harald H Quick; Gerald Antoch; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-08       Impact factor: 9.236

2.  Diffusion-weighted MRI and PET-CT in the follow up of chronic periaortitis.

Authors:  L Kamper; N M Dreger; A S Brandt; T Pöppel; N Abanador-Kamper; S Roth; P Haage
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-15       Impact factor: 2.357

Review 3.  PET/MRI: Where might it replace PET/CT?

Authors:  Eric C Ehman; Geoffrey B Johnson; Javier E Villanueva-Meyer; Soonmee Cha; Andrew Palmera Leynes; Peder Eric Zufall Larson; Thomas A Hope
Journal:  J Magn Reson Imaging       Date:  2017-03-30       Impact factor: 4.813

4.  Integrated PET/MRI for whole-body staging of patients with primary cervical cancer: preliminary results.

Authors:  Johannes Grueneisen; Benedikt Michael Schaarschmidt; Martin Heubner; Bahriye Aktas; Sonja Kinner; Michael Forsting; Thomas Lauenstein; Verena Ruhlmann; Lale Umutlu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-22       Impact factor: 9.236

5.  Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.

Authors:  Youssef Erfanian; Johannes Grueneisen; Julian Kirchner; Axel Wetter; Lars Erik Podleska; Sebastian Bauer; Thorsten Poeppel; Michael Forsting; Ken Herrmann; Lale Umutlu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-31       Impact factor: 9.236

6.  Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study.

Authors:  Hongzan Sun; Jun Xin; Shaomin Zhang; Qiyong Guo; Yueyue Lu; Wei Zhai; Long Zhao; Weiai Peng; Baijun Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-25       Impact factor: 9.236

Review 7.  Clinical applications of PET/MRI: current status and future perspectives.

Authors:  Felix Nensa; Karsten Beiderwellen; Philipp Heusch; Axel Wetter
Journal:  Diagn Interv Radiol       Date:  2014 Sep-Oct       Impact factor: 2.630

8.  Emerging clinical applications of PET based molecular imaging in oncology: the promising future potential for evolving personalized cancer care.

Authors:  Vandana K Dhingra; Abhishek Mahajan; Sandip Basu
Journal:  Indian J Radiol Imaging       Date:  2015 Oct-Dec

9.  Simultaneous [18F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer.

Authors:  P Brandmaier; S Purz; K Bremicker; M Höckel; H Barthel; R Kluge; T Kahn; O Sabri; P Stumpp
Journal:  PLoS One       Date:  2015-11-09       Impact factor: 3.240

10.  Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancer.

Authors:  Johannes Grueneisen; Karsten Beiderwellen; Philipp Heusch; Paul Buderath; Bahriye Aktas; Marcel Gratz; Michael Forsting; Thomas Lauenstein; Verena Ruhlmann; Lale Umutlu
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.